Reacher Fight Fatigue was the most-read story on Bleeding Cool yesterday, again. Lying In The Gutters is the daily runaround.
The Tigers had plenty of All-Stars in 2025. Now, they've got their Fall Stars, too. Tigers prospects Kevin McGonigle and Max Anderson each were named to the Arizona Fall League's All-Star rosters ...
Every notice remains online forever providing friends and families with a lifelong tribute to their loved one, a safe place ...
The Cowboys miss Micah Parsons, shocker, right? Trading for Maxx Crosby would be a hilarious attempt to rectify their mistake. The Cowboys were widely criticized for trading Parsons to one of the ...
How badly did Kevin Durant want to be back in Texas — the state where he played his college ball — and to be on a team with a legit title chance in the next couple of years? Here’s the answer: Durant ...
Houston Rockets star Kevin Durant has signed a two-year, $90 million contract extension, with a player option for 2027-28, his business partner and Boardroom CEO Rich Kleiman told ESPN on Sunday.
Entering his first season with the Houston Rockets and final year of his current contract, Kevin Durant doesn't appear to have a max extension available to him right now. Per ESPN's Brian Windhorst, ...
Kevin O'Leary joins WIRED to answer the internet's burning questions about investing. Can you "time" your moves the stock market? What stocks and sectors are set to boom in the coming years? Is ...
Fuse Media has unveiled a new partnership with comedian and New York Times bestselling author Kevin “KevOnStage” Fredericks. As part of the collaboration, KevOnStage will develop original, culturally ...
Kevin Young is the poetry editor for The New Yorker, and the author of many books of his own poetry. His newest work, “Night Watch,” focusses on death, while also drawing upon his wide view of history ...
Canada Pension Plan Investment Board hired the former chief investment strategist for Alberta’s pension fund, Kevin Bong, to lead efforts in constructing portfolios and setting investment targets.